P2RY11

purinergic receptor P2Y11, the group of P2Y receptors

Basic information

Region (hg38): 19:10111693-10115372

Links

ENSG00000244165NCBI:5032OMIM:602697HGNC:8540Uniprot:Q96G91AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the P2RY11 gene.

  • not_provided (23 variants)
  • not_specified (12 variants)
  • PPAN-P2RY11-related_disorder (8 variants)
  • P2RY11-related_disorder (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the P2RY11 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002566.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
27
clinvar
6
clinvar
33
missense
4
clinvar
4
clinvar
3
clinvar
11
nonsense
1
clinvar
1
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 4 32 9
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
P2RY11protein_codingprotein_codingENST00000321826 23835
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.007710.5661245660111245770.0000442
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.473232571.260.00001782329
Missense in Polyphen9579.0251.2021835
Synonymous-3.821761221.440.00000914830
Loss of Function0.15033.290.9111.41e-732

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008710.0000871
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00004510.0000449
Middle Eastern0.000.00
South Asian0.00006540.0000653
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for ATP and ADP coupled to G-proteins that activate both phosphatidylinositol-calcium and adenylyl cyclase second messenger systems. Not activated by UTP or UDP.;
Pathway
Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Other;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;P2Y receptors;G alpha (s) signalling events;Nucleotide-like (purinergic) receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.135

Intolerance Scores

loftool
0.708
rvis_EVS
0.3
rvis_percentile_EVS
71.68

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.146
ghis
0.532

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Gene ontology

Biological process
adenosine receptor signaling pathway;defense response;G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;phospholipase C-activating G protein-coupled receptor signaling pathway;calcium-mediated signaling;neuronal signal transduction;G protein-coupled purinergic nucleotide receptor signaling pathway;cellular response to ATP
Cellular component
plasma membrane;integral component of plasma membrane
Molecular function
neurotransmitter receptor activity;signaling receptor activity;G protein-coupled purinergic nucleotide receptor activity;ATP-activated adenosine receptor activity